According to the media report on Saturday, the Pakistani health authorities launched measures to ensure pharmaceutical supplies in response to the suspension of business ties with India.
In response to India’s decision to suspend Indus’s water agreement after the Pahalgam Islamabad attack on Thursday, he suspended all the new Delhi trade.
Geo News said India Trade Halt has launched “urgent measures to ensure” pharmaceutical needs in Pakistan and the health authorities, “emergency readiness” measures to ensure supplies.
The Pakistani Regulatory Authority for Drugs (DRAP) confirmed that although there was no formal announcement of the impact of the BAN on the pharmaceutical sector, conditional plans already exist, he said.
Also read | Terrorist attack PAHALGAM: DELHI sets a term for then Nationals to end
“After the 2019 crisis, we started to prepare for such unforeseen events. Now we are actively looking at alternative ways to meet our pharmaceutical needs,” the report said as a proverb of a senior official.
At present, Pakistan relies on India for 30% to 40% of its pharmaceutical raw materials, including active pharmaceutical components (APIs) and various advanced therapeutic products.
With this distribution supply chain, Drag is looking for alternative sources from China, Russia and several European countries.
The aim of the agency is to ensure continuous availability of basic medical supplies, including rabbin vaccines, poison eater, cancer therapy, monoclonal antibodies and other critical biological products.
While DRAP readiness offers some assurance, industry’s initiates and health experts warned against the upcoming challenge unless there were immediate measures to manage a trade SPEAs.
Also read | Army chief then Army gene Munir repeats the theory of “two countries” after the attack of Pahalgam
“Pakistan imports about 30% -40% of their pharmaceutical raw materials from India. We also import finished products, most important, anti-cancer therapy, biological products, vaccines and sera, especially against Rabins and anti-poisoning from India.”
The Ministry of Health has yet to receive an official directive that explains the status of pharmaceutical imports, although the government’s blanket announcement suspends all trade in India.
The pharmaceutical sector fears that disruption in the supplier chain could lead to critical deficiency.
The situation is further complicated by the existence of a robust black market, where unregistered and unapproved drugs are smuggled into Pakistan via Afghanistan, Iran, Dubai and even across the eastern border, reporting in the report.
While these channels fill the gaps left by legal imports, they offer no quality guarantee or consistent offer.
Delegation of the pharmaceutical industry leaders traveled to Islamabad on Thursday to Islamabad to refer to the liberation from the ban on business.
“We had meetings with DRAP and the Ministry of Trade officials to discuss the suspension of business ties. We urged to liberate the pharmaceutical sector from the ban because there are many life products whose raw materials come exclusively from India,” said Tauqeer-Hhaq
The PPMA delegation also approached the special Council for facilitating investment (SIFC), claiming that pharmaceutical and health -related health must be excluded from the ban on the protection of patient lives.
However, some experts consider the current crisis to be awakening for long -term investments in local API, vaccines and biological substances.
“This crisis could be a turning point for Pakistan,” said Zafar IQball, head of public health expert.
On Tuesday, terrorists launched fire in Pahalgamu Jammu and Kashmir and killed 26 people, mostly tourists, in the deadliest attack in the Pulwam strike in 2019.
(Tagstotranslate) India
